JP Morgan Chase’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-435
Closed -$1.45K 7712
2025
Q3
$1.45K Buy
+435
New +$1.51K ﹤0.01% 6952
2022
Q3
Sell
-671
Closed -$93K 6781
2022
Q2
$93K Sell
671
-44
-6% -$6.58K ﹤0.01% 5444
2022
Q1
$117K Sell
715
-3
-0.4% -$454 ﹤0.01% 5430
2021
Q4
$124K Buy
718
+24
+3% +$5.07K ﹤0.01% 5585
2021
Q3
$162K Hold
694
﹤0.01% 5338
2021
Q2
$189K Sell
694
-27
-4% -$7.51K ﹤0.01% 5274
2021
Q1
$198K Buy
721
+108
+18% +$35.2K ﹤0.01% 5154
2020
Q4
$183K Buy
+613
New +$195K ﹤0.01% 4836

Other funds holding PYPD

JP Morgan Chase's PYPD Position: Q4 2025 in Review

JP Morgan Chase sold out of PolyPid (PYPD) in Q4 2025, closing a stake of 435 shares — an estimated $1.45K sold.

JP Morgan Chase first reported a position in PYPD in Q4 2020 and held it in 8 quarters. The position peaked at $198K in Q1 2021. 19 funds tracked by Wall St. Rank hold PYPD as of Q4 2025.

  • JP Morgan Chase reported no remaining PolyPid position as of Q4 2025 after selling out during the quarter.
  • JP Morgan Chase sold 435 PolyPid shares in Q4 2025, an estimated $1.45K.
  • JP Morgan Chase first reported a position in PolyPid in Q4 2020 and held it in 8 quarters.
  • JP Morgan Chase's PolyPid position peaked at $198K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held PolyPid as of Q4 2025.

Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.